Indian Inhaler Market Trends, Size, Competitive Analysis and Forecast 2019-2025
Indian inhaler market is anticipated to grow at a substantial rate of 7.4% during the forecast period. Major factors that augments the growth of the market include large population base susceptible to asthma and COPD, rising awareness about treatment for asthma and COPD, and significant presence of market players in the country. The Indian inhaler market is segmented on the basis of device, type, application, and end-user. On the basis of device, the market is sub-segmented into metered dosed inhaler, dry powdered inhaler, and nebulizer. The dry powder inhaler is estimated to have largest market share in the Indian inhaler market due to providing easy inhalation solution. Based on the type, preventive, reliever, and long acting bronchodilators inhaler are analyzed. Moreover, on the basis of application, the market has been classified into asthma and COPD diseases. In addition, based on the end-user, homecare and hospitals and clinics have been analyzed.
To Request a Sample of our Report on Indian Inhaler Market: https://www.omrglobal.com/request-sample/indian-inhaler-market
Cipla is one of the major companies
working in the inhaler market. The company offers products in the field of
asthma, COPD, Allergic Rhinitis (AR), Pulmonary Arterial Hypertension (PAH),
lung cancer and Idiopathic Pulmonary Fibrosis (IPF). In May 2018, the company
established a partnership with MannKind for marketing and distributing Afrezza.
It is the only US FDA approved inhaled insulin available for patients suffering
from diabetes. In addition, the company in February 2018, has entered into a
partnership with Roche Pharma India for healthcare improvement and increasing
access of life-changing medicines in India.
A
full Report of Indian Inhaler Market is Available at: https://www.omrglobal.com/industry-reports/indian-inhaler-market
Indian
Inhaler Market Segmentation
·
Metered
Dose Inhaler
·
Dry
Powder Inhaler
·
Nebulizer
By Type
·
Preventive
Inhaler
·
Reliever
Inhaler
·
Long
Acting Bronchodilators Inhaler
·
By
Application
·
Asthma
·
Chronic
Obstructive Pulmonary Disease (COPD)
By End-User
·
Homecare
·
Hospitals
and Clinics
Company
Profiles
·
3M Co.
·
Acorda
Therapeutics, Inc.
·
Adamis
Pharmaceuticals Corp.
·
Adherium
Ltd.
·
Aradigm
Corp.
·
AstraZeneca
PLC
·
Beximo
Pharmaceuticals Ltd.
·
Boehringer
Ingelheim International GmbH
·
Cipla
Ltd.
·
GlaxoSmithKline
PLC
·
Koninklijke
Philips N.V.
·
MidasCare
Pharmaceutical Pvt. Ltd.
·
Novartis
AG
·
Omron
Healthcare Inc.
·
Sunovion
Pharmaceuticals
·
Teva
Pharmaceuticals Industries Ltd.
Reasons to Buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More Customized Data, Request for
Report Customization @ https://www.omrglobal.com/report-customization/indian-inhaler-market
About Orion
Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
For
More Information, Visit Orion Market Research
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment